TSLP and chronic obstructive pulmonary disease: Nonetheless, more clinical trials are ongoing to evaluate tezepelumab efficacies in other TSLP-mediated allergic, inflammatory, and autoimmune disorders that include severe chronic rhinosinusitis with nasal polyposis, chronic obstructive pulmonary disease, and chronic spontaneous urticaria.